Cargando…
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
Inflammatory disease states (infection, arthritis) are associated with reduced drug oxidation by the cytochrome P450 3A system. Many chemotherapy agents are metabolised through this pathway, and disease may therefore influence inter-individual differences in drug pharmacokinetics. The purpose of thi...
Autores principales: | Rivory, L P, Slaviero, K A, Clarke, S J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364233/ https://www.ncbi.nlm.nih.gov/pubmed/12177794 http://dx.doi.org/10.1038/sj.bjc.6600448 |
Ejemplares similares
-
Use of Drugs that Act on the Cytochrome P450 System in the Elderly
por: Cabrera, Marcos A S, et al.
Publicado: (2009) -
Cytochrome P450 Enzymes and Drug Metabolism in Humans
por: Zhao, Mingzhe, et al.
Publicado: (2021) -
End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s
por: Déri, Máté Tamás, et al.
Publicado: (2020) -
Hepatic Transcript Profiles of Cytochrome P450 Genes Predict Sex Differences in Drug Metabolism
por: Fuscoe, James C., et al.
Publicado: (2020) -
Effect of health foods on cytochrome P450-mediated drug metabolism
por: Sasaki, Takamitsu, et al.
Publicado: (2017)